or Try an Advanced Search...

    Treatment Of Major Depressive Disorder Stocks List

    Symbol Grade Name % Change
    BWAY A Brainsway Ltd. 2.30
    PRAX B Praxis Precision Medicines, Inc. -2.37
    VNDA D Vanda Pharmaceuticals Inc. 0.22
    VTGN F VistaGen Therapeutics, Inc. 0.97
    NERV F Minerva Neurosciences, Inc 9.39
    BDRX F Biodexa Pharmaceuticals plc -3.90
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Major Depressive Disorder Depressive Disorder Biopharmaceutical Neuroscience Schizophrenia Antidepressants Central Nervous System Disorders Clinical Development Depression Disease Insomnia Mental Health Nervous System Disorders Addiction Alcohol Antisense RNA Brain Tumor Cancer Cartilage Central Nervous System Disease

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Major Depressive Disorder stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 2.49
    MEDX D Horizon Kinetics Medical ETF 0.67
    QQQS A Invesco NASDAQ Future Gen 200 ETF 0.44
    IWC B iShares Microcap ETF 0.39
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.35
    View all Treatment Of Major Depressive Disorder ETFs...
    Compare ETFs
    Compare IBRN to IWC Compare MEDX to LABD Compare QQQS to IWC

        Treatment Of Major Depressive Disorder Stocks Recent News

        Date Stock Title
        Nov 1 VNDA Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
        Nov 1 VTGN Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024
        Nov 1 PRAX Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
        Oct 31 VNDA Vanda started at buy by H.C. Wainwright, negative enterprise value cited
        Oct 31 VNDA Health Care Roundup: Market Talk
        Oct 30 VNDA Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Major Depressive Disorder Depressive Disorder Biopharmaceutical Neuroscience Schizophrenia Antidepressants Central Nervous System Disorders Clinical Development Depression Disease Insomnia Mental Health Nervous System Disorders Addiction Alcohol Antisense RNA Brain Tumor Cancer Cartilage Central Nervous System Disease
        Treatment Of Major Depressive Disorder

        Treatment of major depressive disorder typically involves a combination of psychotherapy and medication. Psychotherapy may include cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), and/or psychodynamic therapy. Medication may include antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). Other treatments may include electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS).

        Browse All Tags